As per reported information, it has got revealed that 13 drug makers and many health organizations have united with the government to eliminate 10 tropical diseases by 2020. Some of the known drug companies and health organizations which have taken the pledge with the government are Astra and Glaxo and the Bill and Melinda Gates Foundation.

A six years old boy was struck by narcolepsy and his parents are of the view that this has been the result of the swine flu vaccination the kid had just received.

A ray of hope has been found to cure people from malaria, as the initial results of the malaria vaccine, RTS, S have proven beneficial, and more than half of the malaria affected children, who received the vaccine, were found to be protected against the virus.

GlaxoSmithKline, maker of a swine flu vaccine, has connected the flu to a sleeping disorder in the children and teenagers, as well as stated Australians were safe and not at risk.

On Friday, US Food and Drug Administration (FDA) gave its approval to GlaxoSmithKline's triple vaccine ‘Boostrix’ – which is a combination vaccine for tetanus, diphtheria and pertussis (whooping cough) - for patients aged more than 65 years.

According to health regulators from the United States, GlaxoSmithKline’s combination vaccine, branded as Boostrix, has been approved for use on seniors.

Neuroscientists will no longer attempt for new research in mental disorders, states a news report. The leading drug companies like UK-based GlaxoSmithKline (GSK) and AstraZeneca declared that they will not work on the psychiatric medication in the treatments like depression, dysthymia and schizophrenia. This announcement is a setback to millions of people who suffer from such problems.

Renowned drug companies, including UK-based GlaxoSmithKline and AstraZeneca, have announced that they do not intend to research new antidepressant drugs. A majority of senior scientists have warned that the decision will leave the families without hope along with a huge financial impact on society.

On Monday, the GlaxoSmithKline PLC and Canadian partner Valeant Pharmaceuticals International Inc. had announced to receive an approval from the U. S. drug regulators for their epilepsy pill Potiga, as an add-on treatment for partial onset seizures, which begins in one side of the brain.

It has been revealed that the Pharmaceutical Giant GlaxoSmithKline has been asked to withdraw a number of medicines. They have been ordered to take back these medicines on the allegation that a few of them contain a chemical additive that is harmful for the use of children.